Latest News

View All

Manufacturing and Packaging
Therapy Focus

Pandemic’s drug-administration risks spotlight benefits of unit dose packaging

Clinical Operations
Information Technology

Advanced analytics: Powering pharma’s most critical data mission

Clinical Operations
Information Technology

Clues and connections from the real world

Brand Marketing / Communications
Information Technology

Next-gen AI: Widespread adoption hinges on trust

Brand Marketing / Communications
Information Technology

Elevating brand outreach in the age of Covid

FEATURES

Effective and proactive oversight of master data

The FDA identifies more than 20,000 prescription drug products as approved for marketing, and there are approximately 900,000 active physicians in the US who can prescribe those drugs. Accounting for all of the pharmaceutical products that ultimately reach patients requires

Data as a strategic asset in the life sciences

Imagine this hypothetical scenario, which is not farfetched in the life sciences industry. Let us assume there is a safety event in a market due to a contaminated drug product and the health authority in that market issues a recall.

AI ‘voice’ grows louder in 2020

The quest to simulate human intelligence in machines has introduced numerous industries to the power of artificial intelligence (AI). In the healthcare and pharmaceutical settings, the past few years have witnessed the advancement and adoption of AI platforms, most notably,

Worthy of further analysis

A recent report by Deloitte projects that the artificial intelligence (AI) drug discovery market will grow 53% by 2025, citing the increased investment of labs in AI as a way to boost research but also to collect, analyze, and produce

Patient support in the time of Covid-19

As social distancing and stay-at-home orders became commonplace in response to the Covid-19 pandemic, many patients chose to put off non-urgent doctor’s visits, eliminating a common point of contact with their healthcare providers. At the same time, millions of Americans have

Navigating Covid turbulence: How biopharmas are adapting their go-to-market strategies

The Covid-19 pandemic has thrust the biopharmaceutical industry into unchartered territory. Unprecedented disruptions to the patient journey and in-person promotional efforts threaten patient health outcomes—as well as the performance of in-line and launch products to treat chronic and complex diseases.

Logistics providers gear up for Covid-19 distribution

In a few weeks, if all goes well with FDA reviews and approvals, Pfizer’s Covid-19 vaccine will begin to be administered to healthcare workers in the US, followed by Moderna’s. We will immediately begin hearing about, on the one hand,